The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
Statement of Douglas W. Blayney, MD, President, American Society of Clinical Oncology,on the U.S. Senate Passage of the Family Smoking Prevention and Tobacco Control Act
ALEXANDRIA, Va. - With today’s historic vote, the U.S. Senate has taken an important step forward in allowing the federal government to counter Big Tobacco’s 100-year assault on public health. Food and Drug Administration (FDA) oversight of the manufacturing and marketing of cigarettes and other tobacco products is long overdue and critical to reducing the toll of cancer in the United States.
Tobacco use is associated with increased risk for at least 15 types of cancer and is responsible for 30 percent of cancer deaths. Lung cancer has emerged from relative obscurity at the start of the 20th Century to become the most common type of cancer today, with 87 percent of all cases attributable to smoking. To reverse this trend, the FDA must be able to step in and regulate these deadly products.
ASCO, which represents more than 27,000 of the cancer doctors and researchers, commends the Senate for its vote and we urge Congress to approve a conference report, which incorporates these provisions, as soon as possible. With 90 percent of adult smokers starting in their teens, we can’t afford to waste any time in passing a bill that protects children from the tobacco industry’s marketing tactics.
